LNTH

#1016
Lantheus Holdings, Inc. - Common Stock
99.3 0 USD
-0.32%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
99.30
99.30
Range Annuel
0.95
103.89
Changement quotidien
-0.32%
Changement Mensuel
+22.34%
Evolution sur 6 mois
+70.01%
Changement Annuel
+77.13%
Clôture Précédente
99.6 2
Open
99.3 0
Low
99.3 0
High
99.3 0
Volume
209
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 6.47 B
  • Employee 1 193
  • Founded N/A
  • CEO N/A
  • Website www.lantheus.com
  • Headquarter Delaware, United States
  • FIGI BBG006Q52RD0
  • Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
19.52
ratio cours/chiffre d'affaires
2.95

Lantheus Holdings, Inc. - Common Stock

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

Nouvelles